Terug
77
Dagbereik
€ 34,21
€ 36,00
52-Weeksbereik
€ 11,26
€ 46,67
Volume
632.511
50D / 200D Gem.
€ 37,72
/
€ 27,42
Vorige Slotkoers
€ 35,50
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -45,0 | 0,3 |
| P/B | 69,3 | 2,9 |
| ROE % | -113,0 | 3,7 |
| Net Margin % | -43,5 | 3,8 |
| Rev Growth 5Y % | 87,3 | 10,0 |
| D/E | 4,4 | 0,2 |
Koersdoel Analisten
Hold
€ 50,67
+43.9%
Low: € 47,00
High: € 55,00
Forward K/W
14,7
Forward WPA
€ 2,41
WPA Groei (sch.)
+0,0%
Omzet Sch.
590 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,12
€ 3,60 – € 8,34
|
1,4 B | 2 |
| FY2029 |
€ 5,66
€ 3,33 – € 7,71
|
1,2 B | 4 |
| FY2028 |
€ 5,09
€ 0,44 – € 8,94
|
1,1 B | 6 |
Belangrijkste Punten
Revenue grew 87,34% annually over 5 years — strong growth
Debt/Equity of 4,42 — high leverage
Negative free cash flow of -40,02M
PEG of 0,83 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 943,84%
Capital efficient — spends only 2,74% of revenue on capex
Groei
Revenue Growth (5Y)
87,34%
Revenue (1Y)1031,18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-112,97%
ROIC-15,88%
Net Margin-43,53%
Op. Margin-32,45%
Veiligheid
Debt / Equity
4,42
Current Ratio1,40
Interest Coverage-2,13
Waardering
P/E Ratio
-45,00
P/B Ratio69,31
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1031,18% | Revenue Growth (3Y) | 200,88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 87,34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158,32M | Net Income (TTM) | -68,92M |
| ROE | -112,97% | ROA | -21,02% |
| Gross Margin | 97,21% | Operating Margin | -32,45% |
| Net Margin | -43,53% | Free Cash Flow (TTM) | -40,02M |
| ROIC | -15,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4,42 | Current Ratio | 1,40 |
| Interest Coverage | -2,13 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -45,00 | P/B Ratio | 69,31 |
| P/S Ratio | 19,59 | PEG Ratio | 0,83 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,10B | Enterprise Value | 3,11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158,32M | 14,00M | 17,49M | 15,94M | 12,85M |
| Net Income | -68,92M | -130,39M | -78,50M | -41,02M | -34,58M |
| EPS (Diluted) | -0,80 | -1,66 | -1,21 | -0,67 | -0,70 |
| Gross Profit | 153,90M | 8,12M | 14,60M | 13,08M | 9,83M |
| Operating Income | -51,38M | -121,29M | -73,38M | -38,77M | -33,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327,93M | 230,31M | 118,33M | 129,20M | 93,73M |
| Total Liabilities | 283,19M | 153,04M | 71,04M | 38,78M | 28,46M |
| Shareholders' Equity | 44,75M | 77,28M | 47,29M | 90,42M | 65,27M |
| Total Debt | 197,93M | 122,39M | 49,54M | 24,46M | 16,08M |
| Cash & Equivalents | 190,68M | 176,48M | 83,68M | 93,28M | 57,49M |
| Current Assets | 190,68M | 185,11M | 89,90M | 99,81M | 61,28M |
| Current Liabilities | 135,77M | 41,78M | 18,55M | 8,80M | 7,33M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#6 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026